CanSino Biologics (HKG:6185, SHA:688185) posted net profit attributable to shareholders of 27.9 million yuan in the third quarter, rising 842% from a year earlier, according to a Monday Hong Kong bourse filing.
Shares of the firm were up nearly 4% in Tuesday afternoon trade.
Earnings per share increased to 0.11 yuan, up 1,000% from the same period last year.
Operating revenue grew nearly 18% year-on-year to 310.2 million yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.